Dr Jay priorities. January revised protocol. T
Post# of 157709
(Total Views: 598)
Posted On: 12/14/2023 4:39:56 PM
Dr Jay priorities.
January revised protocol. Trial started short term. Clinical Data published. CD07 data urgent publication for cancer. Partnership still open to Dr Jay. 2-6 months hopefully. Not committing to anything but it’s a high priority to get a good partnership.
January revised protocol. Trial started short term. Clinical Data published. CD07 data urgent publication for cancer. Partnership still open to Dr Jay. 2-6 months hopefully. Not committing to anything but it’s a high priority to get a good partnership.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
— Jeremiah 51:36
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
— Jeremiah 51:36